CDC20 and neoplasm: CDC20 overexpression is known to be a negative prognostic marker in multiple cancer types (Xian et al, 2022; Wu et al, 2013; Karra et al, 2014; Kato et al, 2012), possibly due to its association with higher tumor cell division rate (Shang et al, 2018; Chu et al, 2019).